Shots:
The biopharma industry faces several challenges, including digital transformation, regulatory compliance, and managing large volumes of data
Intelligent automation plays a vital role in drug discovery, clinical trials, manufacturing, and commercialization, helping optimize operations and better meet customer needs
Astrix CEO Dale Curtis Jr. discusses the role of AI and machine learning in global…
Artificial intelligence (AI) is rapidly transforming ophthalmology, bringing unprecedented precision and safety to eye surgeries. The integration of AI-driven technologies into procedures like LASIK and cataract surgery is revolutionizing patient outcomes, reducing complications, and setting new standards in vision correction.
Advancements in machine learning and surgical robotics enable ophthalmologists to perform complex operations with enhanced…
Top 20 Countries in Health Innovation in 2024
Shots:
By leveraging high-quality research, PharmaShots brings a meticulously prepared guide to the Top 20 Countries in Health Innovation
Using quantitative and qualitative analysis of several aspects encompassing healthcare innovations, PharmaShots dedicatedly navigated the core focus areas of innovations in healthcare while considering trending practices like the…
The pharmaceutical industry is undergoing a significant transformation thanks to digital health innovations. These advancements are not only enhancing patient care but also optimizing drug development processes. Understanding these changes is crucial for staying ahead in a competitive market.
In recent years, digital health technologies have revolutionized various sectors, and the pharmaceutical industry is no…
For decades, the traditional doctor's visit has been the cornerstone of healthcare delivery. Patients schedule appointments, travel to clinics, and wait to see a physician for a snapshot assessment of their health. But this model is undergoing a seismic shift. Remote patient monitoring (RPM) technologies are rapidly transforming how we monitor health, empowering patients and…
Shots:
Meri Beckwith, Co-Founder of Lindus Health engages in a striking conversation with PharmaShots
Meri talks about bridging the gaps of clinical trials in CNS/Neurology by leveraging LLMs that are trained on nearly a million clinical trial protocols and simple machine learning models to monitor real-time clinical trial data
Meri highlights the importance of multidisciplinary…
Shots:
Raviv Pryluk, CEO and Co-Founder of PhaseV, in a stimulating conversation with PharmaShots, sheds light on the company’s recent partnership with 9xchange Biopharma
The partnership aims to bring Phase V’s proprietary machine learning (ML) technology to ecosystem members, enabling them, to retrospectively analyze and optimally design and execute advanced clinical studies
Raviv highlights the…
Shots:
In this reprise, we feature Qiming Venture Partners again, based on the investments in 2023. With more than 600 investments to date, Qiming boasts a strong portfolio of companies involved in Technology & Consumer and Healthcare
In 2023, Qiming closed 38 funding rounds comprising 11 in the first quarter, 10 in the second, 11…
Shots:
The EMA approved 5 BLA and 8 New Chemical Entities in February 2024, leading to treatments for patients and advances in the healthcare industry
In February 2024, the major highlighted drugs were Reblozyl to treat Transfusion-Dependent Anemia and Velsipity for the treatment of Severely Active Ulcerative Colitis
PharmaShots has compiled a list of a total…
In an era prioritizing precision and profound insight, the advancement of imaging solutions has been truly remarkable. Starting from the rudimentary origins of X-ray technology to the intricate multi-modal imaging systems of today, the journey of visualizing the invisible has been characterized by unwavering innovation.
Nonetheless, as the complexity of our inquiries escalates, the sophistication…

